The expenditure on expensive medicines continue to rise, as it turns out Wednesday from preliminary analyses. The expenditure on expensive drugs increased from 1,91 billion euro in 2016 to 2.08 billion in 2017.
That equates to a growth of 9 percent, according to the Monitor expensive medicines in the specialist medical care of the Dutch healthcare authority (NZa). However, it is stressed that the to provisional figures.
Health insurers and hospitals always succeed better in order to lower prices for medicines. But the growth of the number of patients and the advent of new medications lead to the total expenditure on medicines still continue to rise.
The expenditure on expensive medicines increased in recent years faster than the cost for the rest of the medical-specialist care.
In 2017 it went to 8.8 percent of the total expenditure on medical care is on expensive pills. This may come at the expense of other care, the Dutch healthcare authority.
Costs are also likely in future to rise
The supervisor expects that the costs in the coming years continue to rise.
The NZa will investigate whether or not there is a different way of shopping to the expenditure on expensive drugs at manageable levels.